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Abstract
Background and objective
Cardiovascular disease and type 2 diabetes pose a global health burden. Therefore, clarify-
ing the pathology of these risk factors is essential. Previous studies have found positive and
negative associations between one or more cardiovascular risk factors and brain-derived
neurotrophic factor (BDNF) probably due to diverse methodological approaches when ana-
lysing peripheral BDNF levels. Moreover, only a few studies have been performed in youth
populations. Consequently, the main objective of this study was to examine the association
between serum BDNF and a composite z-score consisting of six cardiovascular risk factors.
A secondary aim was to examine the associations between serum BDNF and each of the
six risk factors.
Methods
Four hundred and forty-seven apparently healthy adolescents between 11–17 years of age
participated in this cross-sectional study. Cardiorespiratory fitness (CRF), anthropometrics,
pubertal status, blood pressure (BP), serum BDNF, high-density lipoprotein cholesterol
(HDL-C), triglyceride (TG), blood glucose and insulin were measured. Information about
alcohol consumption and socio-economic status was collected via questionnaires. Associa-
tions were modelled using linear regression analysis.
Results
Serum BDNF was positively associated with the composite z-score in the total study sample
(standardized beta coefficient (std.β) = 0.10, P = 0.037). In males, serum BDNF was posi-
tively associated with the composite z-score (Std. β = 0.14, P = 0.034) and HOMA-IR
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(Std. β = 0.19, P = 0.004), and negatively associated with CRF (Std. β = -0.15, P = 0.026). In
females, BDNF was positively associated with TG (Std. β = 0.14, P = 0.030) and negatively
associated with waist circumference (WC) (Std. β = -0.16, P = 0.012).
Conclusion
Serum BDNF was positively associated with a composite z-score of cardiovascular risk fac-
tors. This association seems to be mainly driven by the association between TG, HOMA-IR
and serum BDNF, and particularly for males. Further longitudinal research is warranted to
determine the temporal relationship between BDNF and cardiovascular risk factors.
Introduction
Lifestyle-related diseases such as cardiovascular disease (CVD) and type 2 diabetes mellitus
(T2DM) are enormous global health burdens. In 2012, these two major non-communicable
diseases caused a total of 19 million deaths worldwide [1]. Risk factors for CVD include hyper-
glycaemia, dyslipidaemia, hypertension and abdominal obesity [2]. These risk factors appear
more often together than by chance alone. In adults this clustering of cardiovascular risk fac-
tors is often referred to as the metabolic syndrome [2]. In children and adolescents, however,
no universal definition of the metabolic syndrome exists [3]. Furthermore, cut-offs are arbi-
trarily chosen as children and adolescents do not fit the adult definition of the metabolic syn-
drome [4]. Therefore, some authors have proposed a continuous composite z-score of risk
factors as a better method to identify children and adolescents with a higher cardiovascular
risk than their peers [3, 5]. By the utilization of this method clustering of cardiovascular risk
factors has been identified in children as young as nine years old [4].
Clarifying the underlying pathology causing the simultaneous rise in the cardiovascular risk
factors is essential for targeting prevention and disease control. Recently, brain-derived neuro-
trophic factor (BDNF) was identified to play a potential role in this amplification [6, 7]. BDNF
is a neurotrophin protein crucial for the differentiation, maturation and survival of neurons.
Together with the other neurotrophin proteins (NGF, NT3 and NT4/5), BDNF modulates
both electrical properties and the structural organization of the synapse by binding to the unse-
lective low-affinity necrosis factor receptor P75NTR and its high-affinity receptor tropomyosin-
related kinase B (TrkB) [8, 9]. High levels of both BDNF and TrkB have been identified in the
hypothalamus, which is a brain region important in appetite- and glucose regulation, weight
control, and energy homeostasis [7, 9]. A recent study found that the deletion of TrkB
(destroying the putative causal chain) in the hypothalamus in mice resulted in increased body
weight, adiposity and impaired glucose homeostasis [10]. It has been hypothesized that BDNF
has metabotrophic potential and may have and important role in cardiometabolic homeostasis
maintenance [11]
Accordingly, a number of studies have examined the association between peripheral BDNF
and one or more of the cardiovascular risk factors in humans, however, results point in differ-
ent directions. Examining the geriatric population, Golden et al. [12] found that circulating
plasma BDNF levels were positively associated with body mass index (BMI), body fat mass,
blood pressure (BP), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C).
This concurs with a study by Levinger et al. [13], who found positive associations between
plasma BDNF levels and triglyceride (TG), plasma glucose, plasma insulin and abdominal fat
in middle-aged healthy individuals. Likewise, Bus et al. [14] found positive associations
Brain-derived neurotrophic factor and cardiovascular risk factors in youth
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between serum BDNF and the presence of metabolic syndrome and coronary heart disease in
adults. However, when analyses were adjusted for age the associations were lost. When exam-
ining single risk factors, Bus et al. [14] only found a positive association between BDNF and
TG. In contrast, a study of patients with angina pectoris found that the associations between
plasma BDNF and TG, LDL-C and the presence of T2DM were inverse [15]. Therefore, the
adult literature is conflicting. El-Gharbawy et al. [16] found that serum BDNF levels were sig-
nificantly lower in extremely overweight children and adolescents compared to normal weight
controls. To our knowledge, no studies have investigated the association between BDNF and
BP, TG, cholesterol and insulin resistance in a healthy population of adolescents. Thus,
research is warranted to clarify these relationships.
The main objective of this study was to examine the association between serum BDNF and
a composite z-score consisting of six cardiovascular risk factors; inverse of high-density lipo-
protein (HDL-C), TG, BP, insulin resistance (HOMA-IR), waist circumference (WC) and
inverse of cardiorespiratory fitness (CRF). As a secondary objective, the associations between
serum BDNF and each of the six risk factors were examined.
Materials and methods
The CHAMPS-study DK
The CHAMPS-study DK was initiated in 2008. It was conducted as a quasi-experimental lon-
gitudinal study evaluating the effects of a tripling of physical education (PE) from 1.5 to 4.5
hours per week in six primary schools in the municipality of Svendborg, Denmark. Four
matched schools served as controls. The primary aim of the CHAMPS-study DK was to assess
the health effects of the PE intervention [17]. The present study solely included results from
the most recent follow-up conducted in 2015. Thus, this study is a cross-sectional analysis. The
extended methods of the CHAMPS-study DK are described elsewhere [18]. Only measure-
ments and methods relevant for this investigation are presented below.
Recruitment and participation
In 2015, 1457 adolescents attending 6th to 10th grade were invited to participate in a follow-up
of the CHAMPS-study DK. In total, 745 subjects provided written informed consent obtained
from a parent or a legal guardian. Of these subjects, 705 of the 1457 adolescents (48% of
invited) participated in the testing. Subjects with metabolic dysfunctions (diabetes, hypergly-
caemia etc.) were excluded (5 subjects). In total, 447 (31% of invited) had complete data and
were included for analyses in this study. The Regional scientific Ethical Committee (Region of
Southern Denmark) approved the 2015 supplemental protocol (Project number: S-20140105).
Data collection
All measurements were collected at the schools in 2015 from February till April. Standardized
and detailed testing protocols were designed to ensure data quality. Experienced research assis-
tants gathered data on anthropometrics, pubertal status, BP and CRF. Trained biomedical lab-
oratory technicians drew all blood samples.
Questionnaires
Two questionnaires were completed; one by a parent/legal guardian and one by the student. In
the parental questionnaire information was gathered about the mother’s level of education,
which was used as indicator of socioeconomic status (SES). SES was coded into four groups (1.
Brain-derived neurotrophic factor and cardiovascular risk factors in youth
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high school or less, 2.vocational education, 3. short tertiary education or 4. bachelor level and
above).
In the student questionnaire information was gathered about alcohol consumption, which
was coded in five groups (1. I never drink alcohol, 2. I drink alcohol less than once a month, 3.
I drink alcohol once a month, 4. I drink alcohol a couple of times a month or 5. I drink alcohol
a couple of times a week). The latter two categories were collapsed due to a low number in
each category leaving four categories.
Anthropometrics and pubertal status
Anthropometric measurements included body mass, height and waist circumference (WC).
Body mass was measured to the nearest 0.1 kg (Tanita BWB-800S, Tanita Corporation, Tokyo,
Japan). Height was measured to the nearest 0.5 cm (SECA 214, Seca Corporation, Hanover,
MD, USA). WC was measured at the level of the umbilicus after a light expiration. Two mea-
surements of body height and WC were conducted and yet another one if the measurements
differed with more than 1 cm. Pubertal status was assessed using the Tanner pubertal stages
self-assessment questionnaires [19]. Subjects were asked to indicate which of five pubertal
stages (pictures) matched themselves in regards to the males’ pubic hair development and
the females’ breast development. The questionnaires were completed in a private, separated
room. Since only one subject belonged to pubertal stage 1, the adolescent was excluded from
analyses.
Cardiorespiratory fitness (CRF)
After a five minutes warm-up and thorough instructions subjects completed an intermittent
running test using the Andersen test protocol [20]. Covered running distance during the test
was reported. Research assistants verbally encouraged all subjects.
Blood pressure
Systolic BP (BPsys) was measured in an isolated room with quiet surroundings. BPsys was
measured after five minutes of rest on the left arm using an automated oscillometric blood
pressure monitor (Omron 705IT, Omron, Kyoto, Japan). The measurement was repeated a
minimum of five times with two minutes intervals and the mean of the three final measures
with readings within five mmHg was used.
Blood samples
Blood samples were collected at the schools after an overnight fast to analyse serum BDNF,
TC, HDL-C, TG, glucose and insulin. Blood samples used for serum BDNF analyses were put
directly on ice. Subsequently, all blood samples were transported to the laboratory. The blood
samples were centrifuged with 1000g for 15 minutes at room temperature. Time between
blood drawing and centrifugation was<4 hours (time was noted). Blood samples were stored
4–6 months at -80˚C. Sandwich ELISA kits (Quantikine, R&D Systems, Minneapolis, MN,
USA) were used to measure levels of serum BDNF. Samples were analyzed in duplicates, and
the mean concentrations were used in the statistical analyses. Analyses were performed at the
Centre for Physical Activity Research, Department of Infectious Diseases, Rigshospitalet, Uni-
versity of Copenhagen, Denmark.
TC, TG, glucose and HDL-C were analysed by quantitative determination using enzymatic,
colorimetric method on Roche/Hitachi cobas c system (Roche, Mannheim, Germany). Insulin
was analysed using solid phase enzyme labeled chemiluminescent immunometric assay.
Brain-derived neurotrophic factor and cardiovascular risk factors in youth
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Insulin resistance was estimated by the homeostasis model assessment, HOMA-IR; blood glu-
cose (mmol/L) x insulin (μU/mL) divided by 22.5 [21].
Statistical analyses
Pearson’s chi2 test (categorical data), unpaired t-test (normally distributed data) and Wilcoxon
rank sum test (non-normally distributed data) were used for gender comparisons in the study
population (Table 1). HDL-C, TG, BPsys, HOMA-IR, WC and CRF were the risk factors
included in the composite z-score. Before generating the composite z-score, variables (risk fac-
tors) that did not follow a normal distribution were log-transformed (insulin, TG and WC).
Furthermore, HDL-C and CRF were multiplied by -1 (only in the composite score) as these
variables are inversely related to cardiovascular health. Risk factors were standardized by
regressing age, gender and pubertal status on the respective risk factors and calculating the
standardized residuals. These residuals are by definition independent of the predictor variable
with a mean of zero and a standard deviation of one. WC and BPsys were further standardized
by height, and all blood measurements (except BDNF) were standardized by weekday as
Table 1. Characteristics of the study population stratified by gender.
Females Males
Number 214 233
Age (years) 14.09 (1.29) 14.44 (1.26)*
Body height (cm) 164.28 (7.10) 170.00 (11.15)*
Body weight (kg) 53.31 (8.87) 55.98 (12.19)*
Body-mass index (kg/m2) 19.68 (2.51) 19.16 (2.42)*
Waist circumference (cm) a 70.00 (66.00–74.75) 71.50 (67.75–76.50)*
Serum BDNF (ng/ml) 26.98 (6.05) 27.01 (6.34)
Insulin resistance (HOMA-IR) a 1.48 (1.14–1.98) 1.20 (0.88–1.68)*
Total cholesterol (mg/dl) 155.24 (24.94) 143.67 (23.49)*
High-density lipoprotein cholesterol (mg/dl) 56.93 (13.02) 54.08 (13.25)*
Systolic blood pressure (mm Hg) 105.59 (8.24) 109.58 (8.89)*
Triglyceride (mg/dl) a 64.00 (51.00–80.00) 58.00 (46.00–76.00)*
Cardiorespiratory fitness (m) 1046.79 (95.47) 1146.75 (104.41)*
Standardized composite z-score 0.00 (1.03) 0.00 (0.97)
Tanner stage (%)
1
2
3
4
5
0%
4%
42%
44%
10%
0%*
9%
26%
45%
19%
Socio-economic status (%)
High school or less
Vocational education
Short tertiary education
Bachelor level and above
7%
26%
11%
56%
6%
31%
14%
49%
Alcohol consumption (%)
I drink a couple of times a month
I drink once a month
I drink less than once a month
I never drink
11%
8%
9%
72%
16%
4%
13%
67%
Characteristics presented as percentage, mean (SD) or median (interquartile range).
a: Variables expressed as median (interquartile range) due to non-normality.
*: Significant difference between gender (P<0.05).
https://doi.org/10.1371/journal.pone.0186384.t001
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preliminary analyses revealed an association between weekday and TG and insulin. This obser-
vation has been reported elsewhere [22]. The final composite z-score was a mean of the six
included risk factors (z-scores). The composite score was converted to a standardized value. A
higher value represents a less favourable risk profile.
The association between serum BDNF and the composite z-score was examined using lin-
ear regression analysis. The analyses were adjusted for age, gender (unless stratified), pubertal
status, SES and alcohol consumption. Further inclusion of a “random-effect” at the school-
class level to model any within-cluster correlation revealed that only 5.4% of the variation
(ICC = 0.054) was explained at this level, hence we modelled the association using the more
parsimonious ordinary least squares model. Regression analyses examining the association
between serum BDNF and single risk factors were conducted using the same statistical
approach and adjustments as above. In a separate model we included a multiplicative interac-
tion term between gender and BDNF. Prior to analyses we specified a secondary gender-strati-
fied model because platelet BDNF levels may vary across the female menstrual cycle [23] and
we only include the gender x BDNF interaction term to formally test for difference in slopes
(Wald test) between the genders. All models were examined for assumptions of normality and
homoscedasticity of residuals and for linearity between independent and dependent variables.
All analyses were completed using Stata 14.0 (StataCorp, College Station, Texas, USA). We
used α<0.05 (two-sided) as the level of significance.
Results
Characteristics of the study population
Four hundred and forty-seven participants completed all measurements included in this
study. The participants in the analytic sample had significantly lower BMI and HOMA-IR and
significantly higher CRF and height compared to the sample of subjects who had missing data
(S1 Table). Moreover, the two samples were significantly different with respect to alcohol con-
sumption and SES.
Characteristics of the study population are presented in Table 1. Males and females were
significantly different with respect to pubertal status, age, body weight, body height, BMI, WC,
HOMA-IR, TC, HDL-C sysBP, TG and CRF (p<0.05). However, no significant differences
were found between genders in BDNF levels, SES and alcohol consumption (p>0.05).
Associations between serum BDNF and a composite z-score
In the total sample, BDNF levels were significantly and positively associated with the compos-
ite z-score (P = 0.037). When the analyses were dichotomized by sex, BDNF levels were posi-
tively associated with the composite z-score (P = 0.034) for males, but the association was not
significant for females (P = 0.548) (Table 2). Gender and serum BDNF did not interact in pre-
dicting the composite z-score (P = 0.204).
Associations between serum BDNF and single risk factors
In the total sample, serum BDNF levels were positively associated with HOMA-IR (P = 0.001)
and TG (P = 0.004). The same positive association was evident in males between BDNF and
HOMA-IR (P = 0.004). Also BDNF levels were negatively associated with CRF in males
(P = 0.026). In females, serum BDNF levels were positively associated with TG (P = 0.030) and
negatively with WC (P = 0.012) (Table 2).
Brain-derived neurotrophic factor and cardiovascular risk factors in youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0186384 October 13, 2017 6 / 12
Discussion
The main finding in this study is that serum BDNF in apparently healthy 11 to 17 year old ado-
lescents is positively associated with a composite z-score consisting of cardiovascular risk fac-
tors. Analyses examining the associations between serum BDNF and single risk factors
revealed that especially TG and HOMA-IR seem to contribute to the positive association
between BDNF and the composite z-score.
The gender x BDNF interaction term did not reach statistical significance when modelling
the composite score as outcome. Previous studies have reported significant differences in
BDNF levels between men and women. These differences may be related to estrogen in the
females, as studies have found that BDNF levels are associated with estrogen levels throughout
the menstrual cycle [24]. Lommatzsch et al. [23] found a significant difference in platelet
BDNF levels (which are closely related to serum BDNF levels) between women in the first and
the last half of the menstrual cycle. Therefore, our choice of a stratification in the analyses was
based on an a priory expectation of different BDNF levels between the genders. It was seen that
the association between BDNF and the composite z-score was driven mainly by the significant
association found in males, and the effect size was about four times larger compared to
females. These observations should be interpreted in the light of the weakened precision of our
estimates when performing stratified analyses and we notice that the sex-specific confidence
intervals are wide and overlap. The assumed fluctuating BDNF levels in females (due to
BDNF’s association with estrogen levels) may have concealed or blurred a potential association
between BDNF and the composite z-score in females. We did not inquire details about the
menstruation cycle of participants in our study due to privacy concerns. This may be a limita-
tion of our study.
The data revealed an inverse relationship between BDNF and WC in females. To the best of
our knowledge, only one study has examined the association between BDNF and obesity in
children and adolescents [16]. El-Gharbawy et al. [16] found that serum BDNF levels were sig-
nificantly lower in overweight children and adolescents compared to the normal weight con-
trols, which supports the negative association found between BDNF and WC in females in
the present study. Based on these observations, measures of body fatness in children and
Table 2. Associations of serum BDNF (ng/ml) with composite z-score and single cardiovascular risk factors.
Total Males Females
β (95% CI) p-value Std. β β (95% CI) p-value Std. β β (95% CI) p-value Std. β
Standardized composite z-score 0.60 (0.04;1.17) 0.037* 0.10 0.95 (0.07; 1.82) 0.034* 0.14 0.23 (-0.52; 0.97) 0.548 0.04
Insulin resistance (HOMA-IR) 0.93 (0.37; 1.49) 0.001* 0.15 1.19 (0.39; 1.99) 0.004* 0.19 0.64 (-0.17; 1.45) 0.122 0.10
High-density lipoprotein cholesterol -0.15 (-0.72; 0.41) 0.597 -0.02 0.02 (-0.81; 0.84) 0.968 <0.00 -0.23 (-1.00; 0.54) 0.555 -0.04
Blood pressure 0.16 (-0.40; 0.73) 0.570 0.03 -0.12 (-0.96; 0.72) 0.778 -0.02 0.52 (-0.24; 1.28) 0.179 0.09
Triglyceride 0.83 (0.27; 1.40) 0.004* 0.13 0.75 (-0.14; 1.64) 0.097 0.11 0.80 (0.08; 1.52) 0.030* 0.14
Waist circumference -0.33 (-0.89; 0.23) 0.252 -0.05 0.24 (-0.68; 1.15) 0.609 0.03 -0.91 (-1.61; -0.20) 0.012* -0.16
Cardiorespiratory fitness -0.29 (-0.86; 0.27) 0.304 -0.05 -1.00 (-1.87; -0.12) 0.026* -0.15 0.46 (-0.42; 1.33) 0.302 0.07
Regression analyses adjusted for age, gender (unless stratified), pubertal status, SES and alcohol consumption. The standardized composite z-score
includes: insulin resistance, triglyceride, blood pressure, waist circumference, inverse of high-density lipoprotein cholesterol and inverse of cardiorespiratory
fitness. Note that a composite z-score expresses a high cardiovascular risk as HDL-C and CRF have been multiplied by -1 (in the composite z-score only).
Single risk factors are presented as z-scores standardized by age, gender (unless stratified) and pubertal status. Systolic BP and WC were adjusted for
height. All non-BDNF blood measurements are adjusted for weekday.
*and bold values = Significant association.
https://doi.org/10.1371/journal.pone.0186384.t002
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adolescents seem to relate differently to BDNF compared to the other cardiovascular risk fac-
tors. However, WC related to the other cardiovascular risk factors as expected (S2 Table).
Thus, we are unable to explain the inverse association between serum BDNF and WC.
The rationale behind examining the association between BDNF and a composite z-score of
cardiovascular risk factors was to examine whether BDNF levels relate to overall cardiovascu-
lar health. However, the significant association observed between BDNF and the composite z-
score seems to be driven mainly by the association between BDNF and TG and HOMA-IR,
respectively. The positive association found between BDNF and TG has previously been
reported in adults and in the geriatric populations [12, 14, 25, 26]. To our knowledge, this is
the first study reporting the positive association between BDNF and TG in adolescents. Insulin
resistance (HOMA-IR) is strongly associated to coronary heart disease in adults, and it has
been found that HOMA-IR predicts clustering of cardiovascular risk factors in children and
adolescents [27]. A large body of evidence, both in animals and humans, supports the associa-
tion between serum BDNF and insulin resistance and glucose metabolism. However, the direc-
tion of the association differs between studies. Krabbe et al. [28] and Fujimani et al. [29] found
that low BDNF levels in plasma and serum, respectively, were associated with impaired glucose
metabolism and T2DM. Additionally, Karczewska-Kupczewska et al. [30] found that serum
BDNF levels in non-obese women with low insulin sensitivity were decreased compared to
women with high insulin sensitivity. On the other hand, Boyuk et al. [26] and Suwa et al. [31]
found increased serum BDNF levels in T2DM patients compared to healthy controls, which
concurs with the findings in the present study. Chaldakov [11] has previously found that circu-
lating BDNF levels are decreased in subjects with advanced metabolic syndrome, whereas
BDNF levels are elevated in subjects in the early stages of metabolic disturbances. If BDNF lev-
els change concurrently with the development of metabolic disturbances, this could be a possi-
ble explanation for the conflicting results in the field.
Methodological challenges in BDNF analysis
In recent years numerous methodological challenges regarding BDNF analyses have been
highlighted and discussed [32]. Since CNS levels of BDNF are difficult to measure in humans,
peripheral levels of BDNF are often used as a proxy. Peripheral BDNF levels can be measured
in serum, plasma, whole blood or platelets. However, it is uncertain which method is the best
reflection of central BDNF levels. Moreover, levels of serum BDNF are not proportionally
related to plasma or whole blood BDNF levels and vice versa [32]. Thus, studies using different
measures of peripheral BDNF levels are not directly comparable. Plasma contains anti-coagu-
lates, whereas serum is prepared after coagulation. Some studies have shown that part of the
BDNF stored in platelets is released during the clotting process, which causes BDNF concen-
trations in serum to increase over time[33]. Therefore, serum BDNF level is sensitive to clot-
ting time and storage duration [34, 35]. Animal models have shown that high BDNF levels in
the hypothalamus seem to have a positive effect on metabolic health, for example on weight
control and glucose regulation [10]. However, in the present study high serum BDNF levels
seem to be associated with a higher cardiovascular risk. One explanation for the observed posi-
tive associations in our study could be an increased platelet activation, which previously has
been observed in pathological conditions (e.g. elevated fasting glucose, endothelia dysfunction
and hypertension) [36, 37], and this may cause an increased platelet BDNF release in serum.
Possibly, peripheral plasma BDNF levels analyzed in platelet-poor plasma would display asso-
ciations with CVD risk more similar to that of brain BDNF level. However, more studies are
needed to clarify this.
Brain-derived neurotrophic factor and cardiovascular risk factors in youth
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The blood samples in the present study were analysed for serum BDNF using ELISA kits.
This equipment does not distinguish between pro-BDNF and mature BDNF, and these two
BDNF variants may lead to different biological responses [32]. The mature BDNF protein,
which binds to its specific TrkB receptor, seems to promote cell survival and maturation. Pro-
BDNF, on the other hand, binds to the p75NTR receptor, which also seems to promote neuro-
nal death and retraction of dendritic spines [38]. The proportions of mature BDNF and pro-
BDNF in cells that express TrkB and P75NTR seem to have the ability to determine the balance
between cell death and cell survival [9]. In pathological conditions, for example in atheroscle-
rosis and diabetes, vascular cells seem to express the pro-BDNF receptor p75NTR promoting
cell apoptosis and inhibiting angiogenesis [39], which may be another explanation for the high
BDNF levels observed in subjects with a high cardiovascular risk. Therefore, a method that dis-
tinguishes between mature BDNF and pro-BDNF could have been relevant in this area of
research, as the direction (positive/negative) and significance of the association between
BDNF and cardiovascular risk factors may depend on the variant of BDNF.
Strengths and limitations
The strength of the present study is the inclusion of a large sample of adolescents. A limited
amount of research has been conducted in this population in this area and most with smaller
sample sizes. Moreover, the large test battery has provided a range of available information
making it possible to adjust for potential confounding factors. Furthermore, the use of a con-
tinuous composite z-score provides a more informative picture of overall cardiovascular risk
compared to a binary assessment of each cardiovascular risk factor [3, 40].
A limitation in the present study is the cross-sectional design making it impossible to con-
clude on causality. Based on these data, it is not possible to conclude whether the high serum
BDNF levels are a cause, consequence, or bi-product of an increased cardiovascular risk.
Moreover, numerous studies have previously concluded that high central BDNF levels are sup-
portive of cardiovascular health, brain health etc. The inverse findings in the present study in
peripheral serum BDNF may indicate that serum BDNF levels do not reflect central BDNF
levels.
Previous studies have found significant associations between serum BDNF and depression,
and BDNF may even play an important role in the association between depression and CVD
[41, 42]. Unfortunately, we did not collect data on depression, which is an additional limitation
in this study.
Another limitation in the present study is the external validity, since the analytic sample dif-
fered significantly from the sample of subjects with missing data (S1 Table). Moreover, this
study population is, according to the biological characteristics, a healthy cohort of young peo-
ple for which reason the observed association between serum BDNF and a composite z-score
(and single risk factors) may be different in other adolescents. Further research is warranted to
verify our results in other cohorts, and also to investigate the possible biological differences in
measuring BDNF in serum, plasma or whole blood, and how this affect the association to car-
diovascular risk factors.
Conclusion
Based on data presented in this study, peripheral serum BDNF seem to be positively associated
with a composite z-score consisting of six cardiovascular risk factors. This association is
mainly driven by the association between serum BDNF and TG and HOMA-IR, respectively,
particularly for males. Further, preferable longitudinal research, is needed to determine the
temporal relationship between BDNF and cardiovascular risk factors.
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Supporting information
S1 Table. Differences between analytic sample and participants with missing data. Charac-
teristics presented as percentages, mean (SD) or median (interquartile range). a: Variables
expressed as median (interquartile range) due to non-normality. : Significant difference
between samples.
(DOCX)
S2 Table. Partial correlation coefficients between cardiovascular risk factors and the com-
posite z-score. All variables are represented as z-scores adjusted for age, gender and pubertal
status. SysBP and WC were adjusted for height. All non-BDNF blood measurements were
adjusted for weekday. and bold values = Significant correlation.
(DOCX)
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